Healing & Tissue Repair Peptides
Peptides researched for tissue repair, wound healing, and recovery acceleration. This category includes BPC-157, TB-500, and other compounds studied for their regenerative properties in tendons, ligaments, gut lining, and soft tissue.
Other Categories
Related Categories
AOD-9604
AOD-9604: HGH fragment for fat loss research. Covers lipolytic mechanism without IGF-1 effects, weight management data, dosing, and GRAS safety status.
BPC-157
BPC-157 peptide comprehensive research guide. Covers mechanism of action (VEGF, nitric oxide, tendon healing), gut protection, musculoskeletal repair, oral vs injectable research, 2026 FDA reclassification status, safety profile, and clinical trial evidence for this gastric-derived healing peptide.
Brimapitide
Brimapitide (AM-111): cell-penetrating JNK inhibitor peptide for sudden hearing loss. Phase 3 HEALOS trial results and intratympanic delivery mechanism.
GHK-Cu
GHK-Cu: Copper tripeptide for skin healing and anti-aging. Covers collagen stimulation, wound repair, hair growth, and topical vs injectable use.
Glepaglutide
Glepaglutide (ZP1848): long-acting GLP-2 analog for short bowel syndrome. Phase 3 data shows significant parenteral support reduction. Twice-weekly dosing.
KPV
KPV (Lys-Pro-Val): alpha-MSH-derived anti-inflammatory tripeptide. Inhibits NF-kB without melanocortin receptors. IBD, gut inflammation, and skin research with dosing data.
Larazotide
Larazotide acetate: zonulin receptor antagonist for celiac disease. Phase 2b/3 results, tight junction regulation, and intestinal permeability reduction.
Linaclotide
Linaclotide: FDA-approved guanylate cyclase-C agonist for IBS-C and chronic constipation. Covers mechanism of action, visceral pain reduction, clinical trial results, and safety profile.
LL-37
LL-37: Human cathelicidin antimicrobial peptide guide. Covers membrane disruption, broad-spectrum antibacterial activity, wound healing, and immunity.
MGF
MGF: Mechano Growth Factor for muscle repair. Covers IGF-1 splice variant mechanism, satellite cell activation, exercise response, and dosing data.
Motixafortide
Motixafortide (APHEXDA): FDA-approved CXCR4 antagonist peptide for stem cell mobilization in multiple myeloma. 92.5% success rate in GENESIS Phase 3 trial.
Nomlabofusp
Nomlabofusp (CTI-1601): TAT-frataxin fusion protein for Friedreich ataxia. Phase 2 complete, BLA planned Q2 2026. First disease-modifying FA therapy.
PEG-MGF
PEG-MGF: PEGylated Mechano Growth Factor with extended half-life. Covers satellite cell activation, muscle regeneration research, and MGF comparison.
Risuteganib
Risuteganib (Luminate/ALG-1001): first-in-class integrin-regulating peptide for dry AMD. Phase 2a showed 48% of patients gained 8+ ETDRS letters vs 7% sham.
Rusfertide
Rusfertide (PTG-300): hepcidin mimetic peptide for polycythemia vera. Phase 3 VERIFY showed 77% response rate. FDA Breakthrough Therapy designation.
TB500
TB-500: Thymosin beta-4 guide for tissue repair and healing. Covers actin regulation, wound healing, cardioprotective research, dosing, and side effects.
Teduglutide
Teduglutide (Gattex/Revestive): FDA-approved GLP-2 analog for short bowel syndrome. Promotes intestinal growth and reduces parenteral nutrition dependence.
Head-to-Head Comparisons
Detailed comparisons between healing & tissue repair peptides covering mechanisms, efficacy, side effects, and research evidence.
Related Articles
FDA Peptide Categories Explained: Category 1 vs Category 2 (2026)
Understand the FDA peptide classification system. Learn the difference between Category 1, Category 2, and Category 3 peptides and what the 2024-2026 regulatory changes mean for researchers.
guideWeight Loss Peptides: Mechanisms, Evidence, and How They Compare
A mechanism-focused guide to weight loss peptides — how GLP-1, GIP, and glucagon pathways drive fat loss, how single, dual, and triple agonists compare, and what the clinical evidence actually shows.
guidePeptide Stacking Guide 2026: Best Combinations by Goal
The definitive 2026 guide to peptide stacking organized by goal. Fat loss, muscle growth, healing, anti-aging, and cognitive stacks with evidence levels, dosing timing, and safety considerations.
guideWeight Loss Peptides for Beginners: Understanding Your Options in 2026
A beginner-friendly guide to weight loss peptides in 2026, covering GLP-1 agonists, dual and triple agonists, non-GLP-1 alternatives, and how to evaluate the evidence behind each option.
guidePeptides for Physical Performance and Endurance: What the Research Shows
An evidence-based guide to peptides studied for physical performance, endurance, and exercise capacity — including MOTS-c, carnosine, tesamorelin, AOD-9604, cortistatin, and BPC-157.
newsFDA Peptide Regulation in 2026: What Is Banned and What Is Legal
FDA peptide regulation in 2026: which peptides are banned from compounding, which remain legal, and what the changes mean for researchers.
Research Tools
Use our interactive tools to explore healing & tissue repair peptides further.